Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Clinical effect of hyperbaric oxygen therapy in the treatment of femoral head necrosis

A systematic review and meta-analysis

Klinische Wirksamkeit der hyperbaren Sauerstofftherapie bei Femurkopfnekrose

Systematische Übersicht und Metaanalyse

Abstract

Background

Although many clinical studies have shown that hyperbaric oxygen (HBO) therapy in the treatment of femoral head necrosis can significantly improve clinical symptoms and patients’ quality of life, this conclusion has not been systematically evaluated. Therefore, a meta-analysis was performed to systematically evaluate the clinical effect of HBO therapy in the treatment of femoral head necrosis.

Methods

PubMed, Embase, and Web of Science databases, as well as the reference lists of relevant studies published before August 2016 were systematically searched using terms related to HBO and femoral head necrosis. Fixed or random effects models were used to estimate the pooled risk ratio (RR) with 95% confidence intervals (CI). Several subgroup analyses, sensitivity analyses, and publication bias tests were carried out to explore potential study heterogeneity and bias.

Results

Nine studies involving 305 controls and 318 HBO cases were included. The clinical effect in the HBO therapy group was 4.95-times higher than in the control group (odds ratio, OR = 4.95, 95% CI [3.24,7.55], P < 0.00001) and the difference was statistically significant. According to the principle of subgroup analysis, the population was divided into Asian and non-Asian subpopulations. Subgroup analyses showed that the clinical effect in the HBO therapy group was 4.77-times higher than that of the control group of the Asian subpopulation (OR = 4.77, 95% CI [3.06,7.44], P < 0.00001) and 7.07-times than that of the control group of the non-Asian subpopulation (OR = 7.07, 95% CI [1.77,28.27], P < 0.00001).

Conclusion

The results of this study showed that HBO therapy can significantly improve the clinical treatment effect in patients with femoral head necrosis, and that this treatment approach is worthy of clinical application.

Zusammenfassung

Hintergrund

In vielen klinischen Studien wurde zwar der Nachweis erbracht, dass die hyperbare Sauerstofftherapie (HBO-Therapie) zur Behandlung der Femurkopfnekrose die klinischen Symptome und die Lebensqualität des Patienten signifikant verbessern kann, aber diese Schlussfolgerung ist bisher nicht systematisch untersucht worden. Daher wurde eine Metaanalyse durchgeführt, um die klinische Wirksamkeit der HBO-Therapie systematisch bei Femurkopfnekrose zu ermitteln.

Methoden

Dazu wurden die Datenbanken PubMed, Embase und Web of Science sowie die Literaturverzeichnisse relevanter Studien, die vor August 2016 publiziert worden waren, systematisch unter Verwendung von Schlagwörtern im Zusammenhang mit HBO-Therapie und Femurkopfnekrose durchsucht. Zur Berechnung des gepoolten Risikoverhältnisses (RR) und der 95%-Konfidenzintervalle (95%-KI) wurden Fixed-Effect- oder Random-Effect-Modelle eingesetzt. Verschiedene Subgruppenanalysen, Sensitivitätsanalysen und Test auf Publikationsbias wurden durchgeführt, um potenzielle Studienheterogenität und -bias zu untersuchen.

Ergebnisse

In die Auswertung wurden 9 Studien mit 305 Kontrollen und 318 Fällen mit HBO-Therapie eingeschlossen. Die klinische Wirksamkeit war in der Gruppe mit HBO-Therapie 4,95-mal höher als in der Kontrollgruppe (Odds Ratio, OR: 4,95; 95%-KI: 3,24–7,55; p < 0,00001), dieser Unterschied war statistisch signifikant. Gemäß den Prinzipien der Subgruppenanalyse wurde die Population unterteilt in eine asiatische und eine nichtasiatische Subpopulation. Die Subgruppenanalysen ergaben, dass die klinische Wirksamkeit in der HBO-Therapie-Gruppe 4,77-mal höher als in der Kontrollgruppe der asiatischen Subpopulation war (OR = 4,77, 95%-KI: 3,06–7,44; p < 0,00001) und 7,07-mal höher als die der Kontrollgruppe der nichtasiatischen Subpopulation (OR: 7,07; 95%-KI: 1,77–28,27; p < 0,00001).

Schlussfolgerung

Die Ergebnisse der vorliegenden Studie zeigen, dass eine HBO-Therapie die Wirksamkeit der klinischen Behandlung bei Patienten mit Femurkopfnekrose signifikant verbessern kann und dass dieser Behandlungsansatz es wert ist, klinisch eingesetzt zu werden.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. 1.

    Ehlinger M, Moser T, Adam P et al (2011) Early prediction of femoral head avascular necrosis following neck fracture. Orthop Traumatol Surg Res 97(1):79–88

  2. 2.

    Bohndorf K, Kramer J, Schaeffeler C (2016) Current concepts in diagnosis and classification of non-traumatic adult femoral head necrosis. Osteologie 25(3):151–155

  3. 3.

    Nishino M, Matsumoto T, Nakamura T et al (1997) Pathological and hemodynamic study in a new model of femoral head necrosis following traumatic dislocation. Arch Orthop Trauma Surg 116(5):259–262

  4. 4.

    Bauer GCH (1985) Femoral head necrosis following traumatic hip joint tamponade: a case report. Acta Orthop Scand 56(3):275–276

  5. 5.

    Rackwitz L, Eden L, Reppenhagen S et al (2012) Stem cell-and growth factor-based regenerative therapies for avascular necrosis of the femoral head. Stem Cell Res Ther 3(1):1

  6. 6.

    Wideman RF Jr, Prisby RD (2013) Bone circulatory disturbances in the development of spontaneous bacterial chondronecrosis with osteomyelitis: a translational model for the pathogenesis of femoral head necrosis. Front Endocrinol (Lausanne) 3:183

  7. 7.

    Wang BL, Sun W, Shi ZC et al (2010) Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononuclear cells. Arch Orthop Trauma Surg 130(7):859–865

  8. 8.

    Hausdorf J, Lutz A, Mayer-Wagner S et al (2010) Shock wave therapy for femoral head necrosis – Pressure measurements inside the femoral head. J Biomech 43(11):2065–2069

  9. 9.

    Fukushima W, Fujioka M, Kubo T et al (2010) Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res 468(10):2715–2724

  10. 10.

    Feng Y, Yang SH, Xiao BJ et al (2010) Decreased in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head. Bone 46(1):32–40

  11. 11.

    Chen CH, Chang JK, Lai KA et al (2012) Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter, prospective, randomized, double-blind, placebo-controlled study. Arthritis Rheum 64(5):1572–1578

  12. 12.

    Zhao D, Cui D, Wang B et al (2012) Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone 50(1):325–330

  13. 13.

    Liu G, Wang J, Yang S et al (2010) Effect of a porous tantalum rod on early and intermediate stages of necrosis of the femoral head. Biomed Mater 5(6):065003

  14. 14.

    Zhang Y, Li L, Shi Z et al (2013) Porous tantalum rod implant is an effective and safe choice for early-stage femoral head necrosis: a meta-analysis of clinical trials. Eur J Orthop Surg Traumatol 23(2):211–217

  15. 15.

    Kang JS, Park S, Song JH et al (2009) Prevalence of osteonecrosis of the femoral head: a nationwide epidemiologic analysis in Korea. J Arthroplasty 24(8):1178–1183

  16. 16.

    Hirota Y, Hotokebuchi T, Sugioka Y (1997) Idiopathic osteonecrosis of the femoral head: nationwide epidemiologic studies in Japan. In: Urbaniak JR, Jones JP Jr (eds) Osteonecrosis: etiology, diagnosis, treatment. American Academy of Orthopaedic Surgeons, Rosemont

  17. 17.

    Coventry MB, Beckenbaugh RD, Nolan DR et al (1974) 2012 total hip arthroplasties: a study of postoperative course and early complications. J Bone Joint Surg Am 56(2):273–284

  18. 18.

    Jennings JD, Iorio J, Kleiner MT et al (2015) Intraoperative fluoroscopy improves component position during anterior hip arthroplasty. Orthopedics 38(11):e970–e975

  19. 19.

    Morvan A, Moreau S, Combourieu B et al (2016) Standing radiological analysis with a low-dose biplanar imaging system (EOS system) of the position of the components in total hip arthroplasty using an anterior approach. Bone Joint J 98(3):326–333

  20. 20.

    Roth A, Beckmann J, Smolenski U et al (2015) S3 guideline. Part 2: non-traumatic avascular femoral head necrosis in adults-untreated course and conservative treatment. Z Orthop Unfall 153(5). doi:10.1055/s-0035-1545903

  21. 21.

    Hong YC, Zhong HM, Lin T et al (2015) Comparison of core decompression and conservative treatment for avascular necrosis of femoral head at early stage: a meta-analysis. Int J Clin Exp Med 8(4):5207

  22. 22.

    Johnson AJ, Mont MA, Tsao AK et al (2014) Treatment of femoral head osteonecrosis in the United States: 16-year analysis of the nationwide inpatient sample. Clin Orthop Relat Res 472(2):617–623

  23. 23.

    Gasbarra E, Perrone FL, Baldi J et al (2015) Conservative surgery for the treatment of osteonecrosis of the femoral head: current options. Clin Cases Miner Bone Metab 12(Suppl 1):43

  24. 24.

    Fang T, Zhang EW, Sailes FC et al (2013) Vascularized fibular grafts in patients with avascular necrosis of femoral head: a systematic review and meta-analysis. Arch Orthop Trauma Surg 133(1):1–10

  25. 25.

    Reis ND, Schwartz O, Militianu D et al (2003) Hyperbaric oxygen therapy as a treatment for stage-I avascular necrosis of the femoral head. Bone Joint J 85(3):371–375

  26. 26.

    Bennett M (2011) Hyperbaric oxygen therapy improved both pain scores and range of motion in patients with early idiopathic femoral head necrosis (Ficat stage II).[J]. Diving Hyperb Med 41(2):105

  27. 27.

    Greenland S (1987) Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9(1):1–30

  28. 28.

    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188

  29. 29.

    Hedges LV, Vevea JL (1998) Fixed-and random-effects models in meta-analysis. Psychol Methods 3(4):486

  30. 30.

    Camporesi EM, Vezzani G, Bosco G et al (2010) Hyperbaric oxygen therapy in femoral head necrosis. J Arthroplasty 25(6):118–123

  31. 31.

    Limin C, Qin F, Huizhen G et al (2013) Efficacy of hyperbaric oxygen therapy in the treatment of avascular necrosis of the femoral head. Chin J Mod Med 51(8):141–142

  32. 32.

    Qiong W, Qibiao W, Fengjuan L (2015) Clinical curative effect observation of hyperbaric oxygen treatment of femoral head necrosis. North Pharm 12(6):190–191

  33. 33.

    Zongping X (2015) Study on the clinical effect of hyperbaric oxygen therapy on the necrosis of the femoral head. J Mod Med 21(6):93–94

  34. 34.

    Aijiang Q, Ping C, Ning L et al (2015) Efficacy of hyperbaric oxygen therapy in the treatment of ischemic necrosis of the femoral head. Chin J Med 40:398–399

  35. 35.

    Lingling T (2012) Long term efficacy of hyperbaric oxygen therapy in the treatment of steroid induced avascular necrosis of the femoral head. Jilin University, Changchun

  36. 36.

    Zheng Z, Ling L, Ning M (2009) The curative effect of hyperbaric oxygen therapy for the treatment of femoral head necrosis. J Chin J Rehabil Med 24(10):951–952

  37. 37.

    Xiyun X (2013) The curative effect observation and nursing experience of hyperbaric oxygen therapy on avascular necrosis of the femoral head. Heilongjiang Med (11). doi:10.3969/j.issn.1004-5775.2013.11.040

  38. 38.

    Okubo Y, Bessho K, Fujimura K et al (1999) Comparative study of intramuscular and intraskeletal osteogenesis by recombinant human bone morphogenetic protein-2. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 87(1):34–38

  39. 39.

    Choi Y, Yun JH, Kim CS et al (2012) Sinus augmentation using absorbable collagen sponge loaded with Escherichia coli-expressed recombinant human bone morphogenetic protein 2 in a standardized rabbit sinus model: a radiographic and histologic analysis. Clin Oral Implants Res 23(6):682–689

  40. 40.

    Lee JH, Yu CH, Yang JJ et al (2012) Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier. Spine J 12(3):239–248

  41. 41.

    Park JC, Lee JB, Daculsi G et al (2012) Novel analysis model for implant osseointegration using ectopic bone formation via the recombinant human bone morphogenetic protein-2/macroporous biphasic calcium phosphate block system in rats: a proof-of-concept study. J Periodontal Implant Sci 42(4):136–143

  42. 42.

    Karasuyama K, Yamamoto T, Motomura G et al (2014) Osteonecrosis of the femoral head with collapsed medial lesion. Clin Med Insights Case Rep 7:103

  43. 43.

    Nossa JM, Aguilera B, Márquez W et al (2014) Factors associated with hip arthroscopy complications in the treatment of femoroacetabular impingement. Curr Orthop Pract 25(4):362–366

  44. 44.

    Muhonen A, Muhonen J, Lindholm TC et al (2002) Osteodistraction of a previously irradiated mandible with or without adjunctive hyperbaric oxygenation: an experimental study in rabbits. Int J Oral Maxillofac Surg 31(5):519–524

  45. 45.

    Okubo Y, Bessho K, Fujimura K et al (2003) Preclinical study of recombinant human bone morphogenetic protein-2: application of hyperbaric oxygenation during bone formation under unfavourable condition. Int J Oral Maxillofac Surg 32(3):313–317

Download references

Acknowledgements

This work was supported by grants from the leading talents of science in Liaoning 2010 (022), the key discipline construction of evidence-based public health in Liaoning.

Author information

Correspondence to Dewei Zhao MD.

Ethics declarations

Conflict of interest

W. Li , Z. Ye , W. Wang , K. Wang, L. Li, and D. Zhao declare that they have no competing interests.

This article does not contain any studies with human participants or animals performed by any of the authors. Institutional review board approval and patient consent were not required for this meta-analysis of observational studies.

Additional information

Wei Wang and Ziliang Ye contributed equally to this work.

Wei Li, Ziliang Ye, and Wei Wang discussed and developed the question for this review; Wei Li and Ziliang Ye carried out the searches; Wei Li, Ziliang Ye, and Wei Wang assessed the eligibility of studies for inclusion, extracted data, and carried out all analyses. All authors were involved in interpretation and discussion of results. Kun Wang wrote the first draft of this paper and it was reviewed by Lang Li and Dewei Zhao. Lang Li and Dewei Zhao were involved in interpretation and discussion of results. All authors agreed on the final draft of this manuscript.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Li, W., Ye, Z., Wang, W. et al. Clinical effect of hyperbaric oxygen therapy in the treatment of femoral head necrosis. Orthopäde 46, 440–446 (2017). https://doi.org/10.1007/s00132-016-3360-8

Download citation

Keywords

  • Asian
  • Bias
  • Bone
  • Microcirculation
  • Pain

Schlüsselwörter

  • Asiaten
  • Bias
  • Knochen
  • Mikrozirkulation
  • Schmerz